Konstantinos Arfanakis to Biomarkers
This is a "connection" page, showing publications Konstantinos Arfanakis has written about Biomarkers.
Connection Strength
0.341
-
MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols. Alzheimers Dement. 2021 04; 17(4):716-725.
Score: 0.147
-
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. J Alzheimers Dis. 2023; 96(2):683-693.
Score: 0.042
-
Vasculocentric Axonal NfH in Small Vessel Disease. J Neuropathol Exp Neurol. 2022 02 24; 81(3):182-192.
Score: 0.040
-
Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
Score: 0.033
-
In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
Score: 0.032
-
Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
Score: 0.026
-
Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
Score: 0.021